Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday

  • Morgan Stanley cut VTEX VTEX price target from $7 to $5.  Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on Friday.
  • Keybanc cut Progyny, Inc. PGNY price target from $55 to $45. Keybanc analyst Scott Schoenhaus maintained an Overweight rating on the stock. Progyny gained 4.1% to close at $31.83 on Friday.
  • SVB Leerink raised the price target on Roivant Sciences Ltd. ROIV from $8 to $10. SVB Leerink analyst David Risinger maintained an Outperform rating on the stock. Roivant Sciences shares gained 1.1% to close at $7.32 on Friday.
  • Raymond James boosted W. P. Carey Inc. WPC price target from $80 to $85. Raymond James analyst RJ Milligan maintained an Outperform rating on the stock. W. P. Carey shares fell 0.1% to $79.73 in pre-market trading.
  • Needham raised AtriCure, Inc. ATRC price target from $55 to $58.. Needham analyst Mike Matson maintained a Buy rating on the stock. AtriCure shares fell 2.6% to close at $41.37 on Friday.
  • JP Morgan cut Glaukos Corporation GKOS price target from $48 to $42. JP Morgan analyst Allen Gong upgraded the stock from Underweight to Neutral. Glaukos shares rose 0.8% to $42.83 in pre-market trading.
  • Jefferies raised Moderna, Inc. MRNA price target from $170 to $275. Jefferies analyst Michael Yee upgraded the stock from Hold to Buy. Moderna shares fell 6.7% to close at $193.29 on Friday.
  • Stifel boosted Xylem Inc. XYL price target from $113 to $115. 170. Stifel analyst Nathan Jones downgraded the stock from Buy to Hold. Xylem shares fell 0.6% to $109.27 in pre-market trading.
  • Piper Sandler raised ConocoPhillips COP price target from $155 to $157. Piper Sandler analyst Ryan Todd maintained an Overweight rating on the stock. ConocoPhillips shares rose 1% to $111.50 in pre-market trading.
  • HC Wainwright & Co. boosted Astria Therapeutics, Inc. ATXS price target from $13 to $20. HC Wainwright & Co. analyst Joseph Pantginis maintained the stock with a Buy rating. Astria Therapeutics shares jumped 4.8% to close at $11.81 on Friday.
  • Baird cut L3Harris Technologies, Inc. LHX price target from $290 to $241. Baird analyst Peter Arment downgraded the stock from Outperform to Neutral. L3Harris Technologies shares fell 1.5% to $210.00 in pre-market trading.

Check out this: 4 Penny Stocks Insiders Are Buying: Getaround, Corvus Pharmaceuticals And More

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: NewsPenny StocksPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsTrading IdeasPrice Target Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!